Raymond James Financial
BCDA icon

Raymond James Financial’s BioCardia BCDA Stock Holding History

Raymond James Financial’s Portfolio BCDA Stock Details BCDA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-1,838
Closed -$3.58K – 5133
2025
Q2 		$3.58K Buy
+1,838
New +$4.09K ﹤0.01% 6267

Other funds holding BCDA

CM
CM Management Gulf Breeze, Florida $157M AUM 60.08% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return
TSS
Two Sigma Securities New York $1.16B AUM 36.23% 1-Year Est. Return
Commonwealth Equity Services
Commonwealth Equity Services Waltham, Massachusetts $79.5B AUM 27.1% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return
XT
XTX Topco George Town, Cayman Islands $7.72B AUM 32.88% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Raymond James Financial's BCDA Position: Q3 2025 in Review

Raymond James Financial sold out of BioCardia (BCDA) in Q3 2025, closing a stake of 1,838 shares — an estimated $3.58K sold.

Raymond James Financial first reported a position in BCDA in Q2 2025 and held it in 1 quarter. The position peaked at $3.58K in Q2 2025. 18 funds tracked by Wall St. Rank hold BCDA as of Q3 2025.

  • Raymond James Financial reported no remaining BioCardia position as of Q3 2025 after selling out during the quarter.
  • Raymond James Financial sold 1,838 BioCardia shares in Q3 2025, an estimated $3.58K.
  • Raymond James Financial first reported a position in BioCardia in Q2 2025 and held it in 1 quarter.
  • Raymond James Financial's BioCardia position peaked at $3.58K in Q2 2025.
  • 18 funds tracked by Wall St. Rank held BioCardia as of Q3 2025.

Based on Raymond James Financial's 13F filing for Q3 2025, filed 14 Nov 2025.